| (R)-noradrenaline | affects abundance | ISO | RGD:69139 | 6480464 | NPPB affects the abundance of Norepinephrine | CTD | PMID:20339970 |
| (R)-noradrenaline | decreases abundance | ISO | RGD:69139 | 6480464 | NPPB protein results in decreased abundance of Norepinephrine | CTD | PMID:16333235 |
| 1,10-phenanthroline | increases expression | ISO | RGD:69139 | 6480464 | 1,10-phenanthroline results in increased expression of NPPB mRNA | CTD | PMID:19502547 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | increases expression | ISO | RGD:69139 | 6480464 | nebivolol results in increased expression of NPPB protein | CTD | PMID:18192850 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:3194 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NPPB mRNA] | CTD | PMID:19969063 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:3194 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NPPB mRNA | CTD | PMID:19969063 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | affects expression | ISO | RGD:3194 | 6480464 | Puromycin Aminonucleoside affects the expression of NPPB mRNA | CTD | PMID:17457379 |
| 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of NPPB | CTD | PMID:15005238 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:69139 | 6480464 | [carvedilol co-treated with temocapril hydrochloride co-treated with Spironolactone co-treated with Aspirin] affects the expression of NPPB protein | CTD | PMID:21378469 |
| acetylsalicylic acid | increases expression | ISO | RGD:3194 | 6480464 | Aspirin results in increased expression of NPPB mRNA | CTD | PMID:12800193 |
| acetylsalicylic acid | affects expression | ISO | RGD:3194 | 6480464 | Aspirin affects the expression of NPPB mRNA | CTD | PMID:12800193 |
| aldosterone | decreases abundance | ISO | RGD:69139 | 6480464 | NPPB protein results in decreased abundance of Aldosterone | CTD | PMID:16333235 |
| aldosterone | affects abundance | ISO | RGD:69139 | 6480464 | NPPB affects the abundance of Aldosterone | CTD | PMID:20339970 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69139 | 6480464 | Tretinoin results in increased expression of NPPB protein | CTD | PMID:20098333 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69139 | 6480464 | Tretinoin results in increased expression of NPPB mRNA | CTD | PMID:21934132 |
| ammonium chloride | affects expression | ISO | RGD:3194 | 6480464 | Ammonium Chloride affects the expression of NPPB mRNA | CTD | PMID:16483693 |
| atenolol | multiple interactions | ISO | RGD:3194 | 6480464 | [Atenolol co-treated with Losartan co-treated with Doxazosin] results in decreased expression of NPPB mRNA; more ... | CTD | PMID:15969258 |
| atenolol | decreases expression | ISO | RGD:3194 | 6480464 | Atenolol results in decreased expression of NPPB mRNA | CTD | PMID:15969258 |
| atenolol | increases expression | ISO | RGD:69139 | 6480464 | Atenolol results in increased expression of NPPB protein | CTD | PMID:18192850 |
| benazepril | multiple interactions | ISO | RGD:3194 | 6480464 | [valsartan co-treated with benazepril] results in decreased expression of NPPB mRNA | CTD | PMID:11136700 |
| benazepril | decreases expression | ISO | RGD:3194 | 6480464 | benazepril results in decreased expression of NPPB mRNA | CTD | PMID:11136700 |
| benzo[a]pyrene | increases expression | ISO | RGD:3194 | 6480464 | Benzo(a)pyrene results in increased expression of NPPB mRNA | CTD | PMID:19889059 |
| benzo[a]pyrene | increases expression | ISO | RGD:69139 | 6480464 | Benzo(a)pyrene results in increased expression of NPPB mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:3194 | 6480464 | Benzo(a)pyrene results in increased expression of NPPB mRNA | CTD | PMID:19889059 PMID:21383588 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:3194 | 6480464 | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Benzo(a)pyrene results in increased expression of NPPB mRNA] | CTD | PMID:21383588 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:3194 | 6480464 | N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine inhibits the reaction [Benzo(a)pyrene results in increased expression of NPPB mRNA] | CTD | PMID:19889059 |
| betaxolol | decreases expression | ISO | RGD:3194 | 6480464 | Betaxolol results in decreased expression of NPPB mRNA | CTD | PMID:12693380 |
| butyric acid | increases expression | ISO | RGD:3194 | 6480464 | Butyric Acid results in increased expression of NPPB mRNA | CTD | PMID:12800193 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of NPPB mRNA | CTD | PMID:20061341 |
| carvedilol | decreases expression | ISO | RGD:69139 | 6480464 | carvedilol results in decreased expression of NPPB protein | CTD | PMID:19367012 more ... |
| carvedilol | decreases expression | ISO | RGD:69139 | 6480464 | carvedilol results in decreased expression of NPPB protein | CTD | PMID:19367012 more ... |
| carvedilol | decreases expression | ISO | RGD:69139 | 6480464 | carvedilol results in decreased expression of NPPB protein | CTD | PMID:20413026 more ... |
| carvedilol | decreases expression | ISO | RGD:69139 | 6480464 | carvedilol results in decreased expression of NPPB protein | CTD | PMID:20413026 more ... |
| carvedilol | increases expression | ISO | RGD:3194 | 6480464 | carvedilol results in increased expression of NPPB mRNA | CTD | PMID:11206715 |
| carvedilol | decreases expression | ISO | RGD:3194 | 6480464 | carvedilol results in decreased expression of NPPB protein | CTD | PMID:19650993 |
| carvedilol | decreases expression | ISO | RGD:3194 | 6480464 | carvedilol results in decreased expression of NPPB mRNA | CTD | PMID:19692266 PMID:19650993 |
| carvedilol | multiple interactions | ISO | RGD:69139 | 6480464 | [carvedilol co-treated with temocapril hydrochloride co-treated with Spironolactone co-treated with Aspirin] affects the expression of NPPB protein | CTD | PMID:21378469 |
| carvedilol | decreases expression | ISO | RGD:3194 | 6480464 | carvedilol results in decreased expression of NPPB mRNA | CTD | PMID:19650993 PMID:19692266 |
| chromium atom | increases expression | ISO | RGD:69139 | 6480464 | Chromium results in increased expression of NPPB mRNA | CTD | PMID:21437242 |
| cobalt dichloride | increases expression | ISO | RGD:69139 | 6480464 | cobaltous chloride results in increased expression of NPPB mRNA | CTD | PMID:19502547 |
| cobalt(2+) sulfate | increases expression | ISO | RGD:69139 | 6480464 | cobalt sulfate results in increased expression of NPPB mRNA | CTD | PMID:19502547 |
| copper atom | increases expression | ISO | RGD:69139 | 6480464 | Copper results in increased expression of NPPB mRNA | CTD | PMID:19747488 |
| copper(0) | increases expression | ISO | RGD:69139 | 6480464 | Copper results in increased expression of NPPB mRNA | CTD | PMID:19747488 |
| copper(2+) sulfate | increases expression | ISO | RGD:69139 | 6480464 | Copper Sulfate results in increased expression of NPPB mRNA | CTD | PMID:19549813 |
| cyclophosphamide | increases expression | ISO | RGD:69139 | 6480464 | Cyclophosphamide results in increased expression of NPPB protein | CTD | PMID:17562616 more ... |
| cyclophosphamide | increases expression | ISO | RGD:69139 | 6480464 | Cyclophosphamide results in increased expression of NPPB protein | CTD | PMID:17562616 more ... |
| cyclophosphamide | increases expression | ISO | RGD:69139 | 6480464 | Cyclophosphamide results in increased expression of NPPB protein | CTD | PMID:18999883 more ... |
| cyclophosphamide | increases expression | ISO | RGD:69139 | 6480464 | Cyclophosphamide results in increased expression of NPPB protein | CTD | PMID:18548196 more ... |
| cyclophosphamide | increases expression | ISO | RGD:69139 | 6480464 | Cyclophosphamide results in increased expression of NPPB protein | CTD | PMID:18999883 more ... |
| cyclosporin A | multiple interactions | ISO | RGD:3194 | 6480464 | Cyclosporine inhibits the reaction [LIF protein results in increased expression of NPPB protein] | CTD | PMID:11073891 |
| cytarabine | increases expression | ISO | RGD:69139 | 6480464 | Cytarabine results in increased expression of NPPB protein | CTD | PMID:16151589 |
| cytarabine | increases expression | ISO | RGD:69139 | 6480464 | Cytarabine results in increased expression of NPPB mRNA | CTD | PMID:21198554 |
| daunorubicin | decreases expression | ISO | RGD:3194 | 6480464 | Daunorubicin results in decreased expression of NPPB mRNA; more ... | CTD | PMID:17673002 |
| daunorubicin | increases expression | ISO | RGD:69139 | 6480464 | Daunorubicin results in increased expression of NPPB protein | CTD | PMID:11279304 |
| dehydroepiandrosterone | decreases expression | ISO | RGD:69139 | 6480464 | Dehydroepiandrosterone results in decreased expression of NPPB mRNA | CTD | PMID:15364798 |
| dexamethasone | multiple interactions | ISO | RGD:69139 | 6480464 | [Thalidomide co-treated with Dexamethasone] results in increased expression of NPPB protein | CTD | PMID:18414984 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NPPB mRNA | CTD | PMID:11804996 |
| diazoxide | increases expression | ISO | RGD:3194 | 6480464 | Isoproterenol results in increased expression of NPPB protein | CTD | PMID:18806606 |
| diazoxide | increases expression | ISO | RGD:3194 | 6480464 | Isoproterenol results in increased expression of NPPB mRNA | CTD | PMID:9043801 |
| diazoxide | multiple interactions | ISO | RGD:3194 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; more ... | CTD | PMID:18806606 |
| digoxin | increases expression | ISO | RGD:69139 | 6480464 | Digoxin results in increased expression of NPPB protein | CTD | PMID:16032632 |
| dioxygen | increases expression | ISO | RGD:69139 | 6480464 | Oxygen deficiency results in increased expression of NPPB mRNA | CTD | PMID:19542490 |
| dioxygen | increases expression | ISO | RGD:69139 | 6480464 | Oxygen deficiency results in increased expression of NPPB mRNA | CTD | PMID:19502547 PMID:19542490 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of NPPB mRNA | CTD | PMID:17193925 |
| dioxygen | increases expression | ISO | RGD:69139 | 6480464 | Oxygen deficiency results in increased expression of NPPB mRNA | CTD | PMID:19542490 PMID:19502547 |
| dioxygen | multiple interactions | ISO | RGD:69139 | 6480464 | Rotenone inhibits the reaction [Oxygen deficiency results in increased secretion of NPPB protein] | CTD | PMID:19542490 |
| dioxygen | increases secretion | ISO | RGD:69139 | 6480464 | Oxygen deficiency results in increased secretion of NPPB protein | CTD | PMID:19542490 |
| dipyridamole | increases expression | ISO | RGD:69139 | 6480464 | Dipyridamole results in increased expression of NPPB protein | CTD | PMID:18037770 |
| docetaxel anhydrous | increases expression | ISO | RGD:69139 | 6480464 | docetaxel results in increased expression of NPPB protein | CTD | PMID:11454849 |
| donepezil hydrochloride | decreases expression | EXP | | 6480464 | donepezil results in decreased expression of NPPB protein | CTD | PMID:19879468 |
| doxazosin | increases expression | ISO | RGD:69139 | 6480464 | Doxazosin results in increased expression of NPPB protein | CTD | PMID:18551024 |
| doxazosin | multiple interactions | ISO | RGD:3194 | 6480464 | [Atenolol co-treated with Doxazosin] results in decreased expression of NPPB mRNA; more ... | CTD | PMID:15969258 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NPPB mRNA | CTD | PMID:17531194 |
| doxorubicin | multiple interactions | ISO | RGD:3194 | 6480464 | Doxorubicin inhibits the reaction [phenylhydrazine results in increased expression of NPPB mRNA] | CTD | PMID:22908232 |
| doxorubicin | increases expression | ISO | RGD:69139 | 6480464 | Doxorubicin results in increased expression of NPPB protein | CTD | PMID:11466716 PMID:11724646 |
| doxorubicin | decreases expression | ISO | RGD:3194 | 6480464 | Doxorubicin results in decreased expression of NPPB mRNA | CTD | PMID:19796650 |
| doxorubicin | increases expression | ISO | RGD:3194 | 6480464 | Doxorubicin results in increased expression of NPPB protein | CTD | PMID:14745153 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of NPPB mRNA | CTD | PMID:16770644 |
| doxorubicin | increases expression | ISO | RGD:69139 | 6480464 | Doxorubicin results in increased expression of NPPB protein | CTD | PMID:11724646 PMID:11466716 |
| enalapril | multiple interactions | ISO | RGD:3194 | 6480464 | Enalapril inhibits the reaction [Isoproterenol results in increased expression of NPPB protein] | CTD | PMID:18806606 |
| formaldehyde | increases expression | ISO | RGD:3194 | 6480464 | Formaldehyde results in increased expression of NPPB mRNA | CTD | PMID:12679049 |
| hydralazine | multiple interactions | ISO | RGD:3194 | 6480464 | Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA] | CTD | PMID:16326922 |
| idarubicin | increases expression | ISO | RGD:69139 | 6480464 | Idarubicin results in increased expression of NPPB protein | CTD | PMID:16151589 |
| isoprenaline | increases expression | ISO | RGD:3194 | 6480464 | Isoproterenol results in increased expression of NPPB mRNA | CTD | PMID:9043801 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NPPB mRNA | CTD | PMID:11804996 |
| isoprenaline | increases expression | ISO | RGD:3194 | 6480464 | Isoproterenol results in increased expression of NPPB protein | CTD | PMID:18806606 |
| isoprenaline | multiple interactions | ISO | RGD:3194 | 6480464 | 2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one inhibits the reaction [Isoproterenol results in increased expression of NPPB protein]; more ... | CTD | PMID:18806606 |
| losartan | multiple interactions | ISO | RGD:3194 | 6480464 | [Atenolol co-treated with Losartan co-treated with Doxazosin] results in decreased expression of NPPB mRNA; more ... | CTD | PMID:15969258 |
| losartan | multiple interactions | ISO | RGD:3194 | 6480464 | [Losartan co-treated with Nifedipine] results in decreased expression of NPPB mRNA | CTD | PMID:17666919 |
| losartan | decreases expression | ISO | RGD:3194 | 6480464 | Losartan results in decreased expression of NPPB mRNA | CTD | PMID:15969258 |
| melphalan | increases expression | ISO | RGD:69139 | 6480464 | Melphalan results in increased expression of NPPB protein | CTD | PMID:18548196 |
| metoprolol | decreases expression | ISO | RGD:3194 | 6480464 | Metoprolol results in decreased expression of NPPB mRNA | CTD | PMID:20353484 |
| metoprolol | decreases expression | ISO | RGD:3194 | 6480464 | Metoprolol results in decreased expression of NPPB protein | CTD | PMID:11181074 |
| monocrotaline | increases expression | ISO | RGD:3194 | 6480464 | Monocrotaline results in increased expression of NPPB mRNA; more ... | CTD | PMID:16936438 |
| nifedipine | multiple interactions | ISO | RGD:3194 | 6480464 | [Losartan co-treated with Nifedipine] results in decreased expression of NPPB mRNA | CTD | PMID:17666919 |
| nitric oxide | multiple interactions | ISO | RGD:3194 | 6480464 | Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA]; more ... | CTD | PMID:16326922 |
| nitric oxide | increases expression | ISO | RGD:3194 | 6480464 | Nitric Oxide deficiency results in increased expression of NPPB mRNA | CTD | PMID:16326922 |
| nitroprusside | decreases expression | ISO | RGD:69139 | 6480464 | Nitroprusside results in decreased expression of NPPB protein | CTD | PMID:20339970 |
| olmesartan | decreases expression | ISO | RGD:3194 | 6480464 | olmesartan medoxomil results in decreased expression of NPPB mRNA | CTD | PMID:16336959 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:3194 | 6480464 | perfluorooctane sulfonic acid results in increased expression of NPPB mRNA | CTD | PMID:22237054 |
| phenylephrine | multiple interactions | EXP | | 6480464 | ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] | CTD | PMID:18502941 |
| phenylephrine | increases secretion | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased secretion of NPPB protein | CTD | PMID:10642269 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11754973 more ... |
| phenylephrine | multiple interactions | ISO | RGD:3194 | 6480464 | CEP-11004 inhibits the reaction [Phenylephrine results in increased secretion of NPPB protein]; more ... | CTD | PMID:20067472 |
| phenylephrine | increases secretion | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased secretion of NPPB protein | CTD | PMID:10642269 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11754973 more ... |
| phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:18502941 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11799083 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11854500 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:12435817 more ... |
| phenylephrine | increases secretion | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased secretion of NPPB protein | CTD | PMID:12435817 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11854500 more ... |
| phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11804996 more ... |
| phenylephrine | increases secretion | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased secretion of NPPB protein | CTD | PMID:12435817 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11799083 more ... |
| phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:16603706 more ... |
| phenylephrine | increases secretion | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased secretion of NPPB protein | CTD | PMID:11754973 more ... |
| phenylephrine | increases expression | ISO | RGD:3194 | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:11754973 more ... |
| phenylephrine | multiple interactions | ISO | RGD:3194 | 6480464 | PDE5A protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; more ... | CTD | PMID:18790048 |
| phenylephrine | multiple interactions | ISO | RGD:3194 | 6480464 | MYOCD protein affects the reaction [Phenylephrine results in increased expression of NPPB mRNA] | CTD | PMID:16556869 |
| phenylephrine | multiple interactions | ISO | RGD:3194 | 6480464 | MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] | CTD | PMID:11854500 |
| phenylephrine | multiple interactions | ISO | RGD:3194 | 6480464 | JUN gene mutant form inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] | CTD | PMID:11799083 |
| phenylephrine | multiple interactions | ISO | RGD:3194 | 6480464 | HS 142-1 promotes the reaction [Phenylephrine results in increased secretion of NPPB protein] | CTD | PMID:10642269 |
| phenylephrine | multiple interactions | ISO | RGD:3194 | 6480464 | [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]; more ... | CTD | PMID:18701451 |
| phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of NPPB mRNA | CTD | PMID:16603706 more ... |
| phenylephrine | multiple interactions | EXP | | 6480464 | HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] | CTD | PMID:16603706 |
| phenylhydrazine | multiple interactions | ISO | RGD:3194 | 6480464 | Doxorubicin inhibits the reaction [phenylhydrazine results in increased expression of NPPB mRNA] | CTD | PMID:22908232 |
| phenylhydrazine | increases expression | ISO | RGD:3194 | 6480464 | phenylhydrazine results in increased expression of NPPB mRNA | CTD | PMID:22908232 |
| pirinixic acid | multiple interactions | ISO | RGD:3194 | 6480464 | [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] | CTD | PMID:18701451 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of NPPB mRNA | CTD | PMID:16985257 |
| prostaglandin E1 | decreases expression | ISO | RGD:69139 | 6480464 | Alprostadil results in decreased expression of NPPB protein | CTD | PMID:16084762 |
| prostaglandin E2 | increases expression | ISO | RGD:3194 | 6480464 | Dinoprostone results in increased expression of NPPB mRNA | CTD | PMID:18030065 |
| quercetin | affects expression | ISO | RGD:3194 | 6480464 | Quercetin affects the expression of NPPB mRNA | CTD | PMID:18178720 |
| ramipril | decreases expression | ISO | RGD:3194 | 6480464 | Ramipril results in decreased expression of NPPB mRNA | CTD | PMID:15667801 |
| resveratrol | decreases secretion | ISO | RGD:3194 | 6480464 | resveratrol results in decreased secretion of NPPB protein | CTD | PMID:17499237 |
| resveratrol | multiple interactions | ISO | RGD:3194 | 6480464 | resveratrol inhibits the reaction [AGT protein results in increased expression of NPPB protein]; more ... | CTD | PMID:18543488 |
| resveratrol | decreases expression | ISO | RGD:3194 | 6480464 | resveratrol results in decreased expression of NPPB mRNA | CTD | PMID:17499237 |
| resveratrol | multiple interactions | ISO | RGD:3194 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NPPB mRNA] | CTD | PMID:19969063 |
| rifampicin | multiple interactions | ISO | RGD:69139 | 6480464 | [Rifampin co-treated with NR1I2 protein] results in increased expression of NPPB mRNA | CTD | PMID:21127053 |
| rosiglitazone | increases expression | ISO | RGD:3194 | 6480464 | rosiglitazone results in increased expression of NPPB mRNA | CTD | PMID:19397913 |
| rosiglitazone | decreases expression | ISO | RGD:3194 | 6480464 | rosiglitazone results in decreased expression of NPPB mRNA | CTD | PMID:21515302 |
| rotenone | multiple interactions | ISO | RGD:69139 | 6480464 | Rotenone inhibits the reaction [Oxygen deficiency results in increased secretion of NPPB protein] | CTD | PMID:19542490 |
| sildenafil | affects expression | ISO | RGD:69139 | 6480464 | sildenafil affects the expression of NPPB protein | CTD | PMID:19179780 |
| sildenafil | multiple interactions | ISO | RGD:3194 | 6480464 | sildenafil inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] | CTD | PMID:18790048 |
| simvastatin | decreases expression | ISO | RGD:3194 | 6480464 | Simvastatin results in decreased expression of NPPB protein | CTD | PMID:21124329 |
| simvastatin | decreases expression | ISO | RGD:3194 | 6480464 | Simvastatin results in decreased expression of NPPB | CTD | PMID:16628357 |
| spironolactone | decreases expression | ISO | RGD:69139 | 6480464 | Spironolactone results in decreased expression of NPPB protein | CTD | PMID:11300427 |
| spironolactone | multiple interactions | ISO | RGD:69139 | 6480464 | [carvedilol co-treated with temocapril hydrochloride co-treated with Spironolactone co-treated with Aspirin] affects the expression of NPPB protein | CTD | PMID:21378469 |
| streptozocin | increases expression | ISO | RGD:3194 | 6480464 | Streptozocin results in increased expression of NPPB mRNA | CTD | PMID:10828832 |
| tacrolimus hydrate | multiple interactions | EXP | | 6480464 | Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPB mRNA] | CTD | PMID:15939815 |
| telmisartan | affects expression | ISO | RGD:69139 | 6480464 | telmisartan affects the expression of NPPB protein | CTD | PMID:16671338 |
| telmisartan | decreases expression | ISO | RGD:69139 | 6480464 | telmisartan results in decreased expression of NPPB protein | CTD | PMID:18712048 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:69139 | 6480464 | tert-Butylhydroperoxide results in increased expression of NPPB mRNA | CTD | PMID:15336504 |
| thalidomide | multiple interactions | ISO | RGD:69139 | 6480464 | [Thalidomide co-treated with Dexamethasone] results in increased expression of NPPB protein | CTD | PMID:18414984 |
| thiabendazole | increases expression | ISO | RGD:3194 | 6480464 | Thiabendazole results in increased expression of NPPB mRNA | CTD | PMID:18539377 |
| trans-resveratrol | decreases secretion | ISO | RGD:3194 | 6480464 | resveratrol results in decreased secretion of NPPB protein | CTD | PMID:17499237 |
| trans-resveratrol | multiple interactions | ISO | RGD:3194 | 6480464 | resveratrol inhibits the reaction [AGT protein results in increased expression of NPPB protein]; more ... | CTD | PMID:18543488 |
| trans-resveratrol | multiple interactions | ISO | RGD:3194 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NPPB mRNA] | CTD | PMID:19969063 |
| trans-resveratrol | decreases expression | ISO | RGD:3194 | 6480464 | resveratrol results in decreased expression of NPPB mRNA | CTD | PMID:17499237 |
| troglitazone | decreases expression | ISO | RGD:3194 | 6480464 | troglitazone results in decreased expression of NPPB mRNA | CTD | PMID:21515302 |
| valsartan | multiple interactions | ISO | RGD:69139 | 6480464 | valsartan inhibits the reaction [CHOP protocol results in increased expression of NPPB protein] | CTD | PMID:16247790 |
| valsartan | decreases expression | ISO | RGD:69139 | 6480464 | valsartan results in decreased expression of NPPB protein | CTD | PMID:12417542 |
| valsartan | decreases expression | ISO | RGD:3194 | 6480464 | valsartan results in decreased expression of NPPB mRNA | CTD | PMID:11136700 |
| valsartan | multiple interactions | ISO | RGD:3194 | 6480464 | [valsartan co-treated with benazepril] results in decreased expression of NPPB mRNA | CTD | PMID:11136700 |